Phase
Condition
Heart Failure
Chest Pain
Hyponatremia
Treatment
Lifestyle advice for liberal fluid intake
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosis of chronic HF with NYHA class II/III according to the prevailingguidelines > 6 months prior to randomization (1)
Adult (age ≥ 18 years)
Exclusion
Exclusion Criteria:
Reversible cause of HF (thyroid disorders, severe anemia, vitamin deficiencies)
Hospital admission for HF within 3 months of randomization
Chronic HF with NYHA class IV
Hyponatremia at baseline (sodium <130mmol/l)
Changes in HF medical therapy in last 14 days prior to randomization
Estimated Glomerular Filtration Rate (eGFR) of < 30ml/min/1.73 m2 at baseline
Scheduled cardiac surgery within 3 months of randomization
Recent (within 3 months) coronary intervention (PCI or CABG) or implantation ofpacemaker device
Comorbidity for which fluid restriction is advised by a different treating physician (e.g. nephrologist)
Comorbidity with a life expectancy of less than 6 months
The treating clinician believes that participation in the domain would not be in thebest interests of the patient
Inability to provide informed consent
Study Design
Connect with a study center
Radboud University Medical Center
Nijmegen, Gelderland 6525GA
NetherlandsSite Not Available
Hospital Group Twente
Almelo,
NetherlandsSite Not Available
Rijnstate Hospital
Arnhem,
NetherlandsSite Not Available
Jeroen Bosch Ziekenhuis
Den Bosch,
NetherlandsSite Not Available
Zuyderland Ziekenhuis
Heerlen,
NetherlandsSite Not Available
Dijklander Ziekenhuis
Hoorn,
NetherlandsSite Not Available
Maastricht University Medical Centre
Maastricht,
NetherlandsSite Not Available
Bernhoven Ziekenhuis
Uden,
NetherlandsSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.